Document ID: chunk:federal_register_of_legislation:F2017C00854:reg:7
Version: federal_register_of_legislation:F2017C00854
Segment Type: reg
Provision Reference: reg 7
Character Range: 3846–5681

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about benign neoplasm of the eye and adnexa and death from benign neoplasm of the eye and adnexa.
Meaning of benign neoplasm of the eye and adnexa
(2)          For the purposes of this Statement of Principles, benign neoplasm of the eye and adnexa means:
(a)          a non-malignant neoplastic proliferation of the cells of the eye classified according to site as conjunctiva, cornea, retina, choroid, ciliary body, lacrimal gland, lacrimal duct and orbit; and
(b)          excludes benign neoplasms of eyelids, optic nerve, meninges and orbital bone; lipoma, haemangioma, lymphangioma, melanocytic naevi, neurofibromatosis, retinal vasoproliferative tumour and ocular surface squamous dysplasia.
(3)          While benign neoplasm of the eye and adnexa attracts ICD‑10‑AM code D31, in applying this Statement of Principles the meaning of benign neoplasm of the eye and adnexa is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5.
Death from benign neoplasm of the eye and adnexa
(5)          For the purposes of this Statement of Principles, benign neoplasm of the eye and adnexa, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's benign neoplasm of the eye and adnexa.
Note: terminal event is defined in the Schedule 1 – Dictionary.